Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Coronavirus Notebook: Regeneron, HHS To Develop Antibody

Tue, 02/04/2020 - 11:49pm

Wuhan Institute of Pathology files patent over new use of Gilead's remdesivir and Regeneron expands collaboration with HHS to include...

      Related Stories 

Ranitidine Recall Dents GSK India, Which Mulls Plant Sale

Tue, 02/04/2020 - 7:20pm

GlaxoSmithKline India’s Vemgal plant, which entailed a large investment outlay, may be put on the block as part of a...

      Related Stories 

Japan Pharma Unconcerned About Virus Impact - For Now

Tue, 02/04/2020 - 6:38pm

Spreading China outbreak not a point of focus for companies or analysts in quarterly results briefings.

      Related Stories 

Gilead Writes Down Kite Buy As Yescarta Sales Flatten Out

Tue, 02/04/2020 - 2:41pm

Gilead takes $800m impairment charge against Kite acquisition a year after an $820m write-down. Kite and Yescarta are appear to...

      Related Stories 

Leo Sets Up For A David & Goliath Showdown In Atopic Dermatitis

Tue, 02/04/2020 - 11:20am

Scrip talked to Leo Pharma's new CEO Catherine Mazzacco about going up against big biopharma players in dermatology and plans...

      Related Stories 

Leo Sets Up For A Samson & Goliath Showdown In Atopic Dermatitis

Tue, 02/04/2020 - 11:20am

Scrip talked to Leo Pharma's new CEO Catherine Mazzacco about going up against big biopharma players in dermatology and plans...

      Related Stories 

Freeline Bags Alnylam's Heggie As CEO

Tue, 02/04/2020 - 7:42am

Syncona-backed Freeline has nabbed an "accomplished commercial leader" in Theresa Heggie to lead the company as it prepares to take...

      Related Stories 

Sanofi Q4 Preview: CEO Hudson’s Planned Revamp Key Focus

Tue, 02/04/2020 - 7:37am

Sanofi’s Q4 update will highlight planned strategic changes and Dupixent’s key growth role, amid a strong rebound in quarterly US...

      Related Stories 

Insmed Goes Full Steam Ahead With Bronchiectasis Candidate

Tue, 02/04/2020 - 7:37am

Insmed shares got a 40% boost as the company announced plans to move into Phase III this year with its...

      Related Stories 

United Therapeutics' Unituxin Disappoints In SCLC

Tue, 02/04/2020 - 4:46am

Targeting gangliosides expressed on SCLC tumors has been explored by United Therapeutics in the Phase II/III DISTINCT study, but top-line...

      Related Stories 

Podcast: Key Takeaways From J.P. Morgan

Tue, 02/04/2020 - 3:31am

Scrip journalists join Datamonitor Healthcare's Mike Ramirez to share their impressions from the 2020 J.P. Morgan conference in San Francisco...

      Related Stories 

Coronavirus Notebook: China Generic Antiviral Filed For Emergency Approval

Mon, 02/03/2020 - 10:29pm

China is tightening oversight over suspected coronavirus cases, allowing hospitals to quarantine patients upon their first visit as confirmed infections...

      Related Stories 

Takeda Ups Guidance On Mainstay Growth, Cost Discipline

Mon, 02/03/2020 - 9:31pm

Recovering underlying revenue, faster integration synergies and global portfolio growth behind upward adjustments in full-year forecasts.

      Related Stories 

Lenvima Stars As Eisai Ups Profit Outlook After Solid Quarter

Mon, 02/03/2020 - 6:25pm

Growing use in liver cancer drives global sales of Lenvima along with the overall performance of Eisai.

      Related Stories 

Finance Watch: Billions Of Dollars In Offerings Despite US Biopharma Stock Slump

Mon, 02/03/2020 - 12:29pm

Blueprint and Zymeworks raise $300m-plus in follow-on offerings. Also, Arcutis, Black Diamond and Annovis bring the 2020 US IPO count...

      Related Stories 

Start-Up Quarterly Statistics: Financings Surged In Q4 While M&A Waned

Mon, 02/03/2020 - 12:12pm

A review of biopharma start-up dealmaking and financing activity from October through December 2019, based on data from Strategic Transactions...

      Related Stories 

GSK Joins Race To Tackle Coronavirus

Mon, 02/03/2020 - 6:09am

The pharma major is providing its adjuvant system, designed to enhance the body’s immune response, to help the Coalition for...

      Related Stories 

Novo Nordisk Q4 Preview: Rybelsus’s Launch Key Focus

Mon, 02/03/2020 - 5:50am

Ozempic's continued good growth and the ongoing roll out of oral Rybelsus should revitalize growth and expand Novo's reach in...

      Related Stories 

Cipla Rejigs Executives, New Chief For North America Business

Mon, 02/03/2020 - 4:49am

Ex-Torrent COO Arunesh Verma to lead Cipla’s North America generics business, while the head of Cipla USA has been repositioned to...

      Related Stories 

Stockwatch: Biosimilars And Dividends Connect Earnings At Pfizer And Roche

Mon, 02/03/2020 - 1:03am

With Brexit and coronavirus depressing markets over the week, earnings season for life science companies shifted into a higher gear...

      Related Stories 

Pages